There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia, according to a study led by researchers at Karolinska Institutet.
Avid Bio’s 2024 revenue drops; Lotte Bio breaks ground on new $3.3B site
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Avid Bioservices’ revenue for fiscal year